In conclusion, the value of CHI3L1 expression in assessing significant liver fibrosis in patients with CHB is clearer and superior to currently known non-invasive diagnostic methods, and it serve as a reliable reference for antiviral therapy. Here, CHI3L1 is linked to Hepatic fibrosis.